CTLA4 and cancer: The CTLA-4 mAb binds specifically to CTLA-4 and prevents CTLA-4 from binding to B7, thereby blocking the CTLA-4 pathway and activating T-lymphocytes to kill cancer cells (Kwak et al. 2020).